Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants

Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis

(2016) Erin R. Weeda et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

(2016) Xiaoxi Yao et al.   Journal of the American Heart Association

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation

(2016) Joshua D. Brown et al.   Journal of Managed Care & Specialty Pharmacy

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure

(2015) Colleen A. McHorney et al.   CURRENT MEDICAL RESEARCH AND OPINION

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

(2015) A. Gorst-Rasmussen et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes

(2015) Peter C Austin et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Meta-Analysis of CHADS2versus CHA2DS2-VASc for Predicting Stroke and Thromboembolism in Atrial Fibrillation Patients Independent of Anticoagulation

(2015) Wen-Gen Zhu et al.   TEXAS HEART INSTITUTE JOURNAL

Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation

(2015) Katsiaryna Bykov et al.   THROMBOSIS AND HAEMOSTASIS

Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration

(2014) Supriya Shore et al.   AMERICAN HEART JOURNAL

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   BLOOD

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

(2014) Craig T. January et al.   CIRCULATION

Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study

(2014) K. F. Enga et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease

(2013) Michael Böhm et al.   AMERICAN HEART JOURNAL

Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin

(2013) Martin Zalesak et al.  

Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study

(2013) Kimmo Herttua et al.   EUROPEAN HEART JOURNAL

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes

(2013) Christina L. Cove et al.   Journal of the American Heart Association

Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation

(2012) Catherine J. Mercaldi et al.   Cardiology Research and Practice

Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation

(2010) Michael D. Ezekowitz et al.   CIRCULATION

Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors

(2010) James P. Burke et al.   CURRENT MEDICAL RESEARCH AND OPINION

Antihypertensive Medication Adherence, Ambulatory Visits, and Risk of Stroke and Death

(2010) James E. Bailey et al.   JOURNAL OF GENERAL INTERNAL MEDICINE